IRIS
Clavio, Marino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.998
AS - Asia 14
NA - Nord America 1
Totale 2.013
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 1.998
CN - Cina 13
SG - Singapore 1
US - Stati Uniti d'America 1
Totale 2.013
Salva come PNG Salva come JPEG
Città #
Genoa 847
Genova 767
Rapallo 218
Vado Ligure 158
Beijing 8
Bordighera 4
Perugia 3
Ashburn 1
Singapore 1
Totale 2.007
Salva come PNG Salva come JPEG
Nome #
A blastic plasmacytoid dendritic cell neoplasm-like phenotype identifies a subgroup of npm1-mutated acute myeloid leukemia patients with worse prognosis 180
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 176
A simple cytofluorimetric score may optimize testing for biallelic CEBPA mutations in patients with acute myeloid leukemia 176
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 165
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomas 163
Combining flow cytometry and WT1 assessment improves the prognostic value of pre-transplant minimal residual disease in acute myeloid leukemia 157
Intesive fludarabine-high dose cytarabine-idarubicin combination as induction therapy with risk-adapted consolidation may improve treatment efficacy in younger Acute Myeloid Leukemia (AML) patients: Rationales, evidences and future perspectives 152
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 145
The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs 145
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 138
Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score-matched analysis 115
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 105
A Blastic Plasmacytoid Dendritic Cell Neoplasm-like Phenotype Identifies a Subgroup of NPM1-Mutated AML Patients with Worse Prognosis While Has Not Predictive Value in NPM1-Wt AML 86
Pre-transplant minimal residual disease assessment and transplant-related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation 58
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice 42
Cryptococcus neoformans fatal sepsis in a chronic lymphocytic leukemia patient treated with alemtuzumab: case report and review of the literature 40
Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information 32
Totale 2.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.663
article - articoli 7.663
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 9 17 21 2 21 15 19 11 24
2021/2022154 3 2 13 20 15 14 8 27 15 11 8 18
2022/2023260 22 27 3 26 49 28 1 14 34 19 31 6
2023/2024212 11 15 3 23 12 47 24 39 4 7 13 14
2024/2025533 13 29 13 31 37 51 67 124 15 26 62 65
2025/2026248 117 18 40 73 0 0 0 0 0 0 0 0
Totale 2.075